Latest filing published 04 Mar 2026 for 盟科药业, €699.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -17.7%Entry CN¥5.65 · Close at T+90 CN¥4.65
- -23.1%Entry CN¥5.80 · Close at T+90 CN¥4.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
金燕: trading record in brief
金燕 (board member) discloses dealings in 盟科药业 to SSE / SZSE (CSRC). We count 2 filings; the first trade dates from 2 March 2026 and the latest from 4 March 2026.
No open-market sale appears; the market trades are 2 purchases worth €2,215. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 4 March 2026: an open-market purchase of €699, in 盟科药业. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 金燕
Open company profiles for insider transactions, fundamentals and analyst consensus when available.